Exercise during chemotherapy: Friend or foe?
Open Access
- 19 April 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (9) , 10715-10724
Abstract
Background: A higher chemotherapy completion rate is associated with better outcomes including treatment efficacy and overall survival. Exercise may have the potential to improve relative dose intensity (RDI) by reducing the frequency and severity of chemotherapy‐related toxicities. We examined the association between exercise adherence and RDI and possible clinical‐ and health‐related fitness predictors of RDI.Methods: Chemotherapy records were extracted from the electronic medical record for patients enrolled in the ENACT trial (n = 105). Chemotherapy completion was assessed using average RDI. A threshold of 85% was established for “high” versus “low” RDI. Logistic regression analyses were used to estimate the associations between the clinical‐ and health‐related fitness predictors of RDI.Results: Patients with breast cancer (BC) had a significantly higher average RDI (89.8% ± 17.6%) compared with gastrointestinal cancer (GI) (76.8% ± 20.9%, p = 0.004) and pancreatic cancer (PC) (65.2% ± 20.1%, p < 0.001). Only 25% of BC patents required a dose reduction compared to 56.3% of GI and 86.4% of PC patients. Cancer site was significantly associated with RDI. Compared with BC, patients with GI (β = −0.12, p = 0.03) and PC (β = −0.22, p = 0.006) achieved significantly lower RDI. Every 2.72 unit increase in overall exercise adherence led to a significant 7% decrease in RDI (p = 0.001) in GI patients. Metastatic GI patients had a 15% RDI increase for every 2.72 unit increase in exercise adherence (p = 0.04).Conclusion: Exercise is a supportive therapy that has potential to enhance chemotherapy tolerance and completion. The relationship between exercise adherence and RDI is influenced by factor such as cancer site and treatment type. Special attention must be paid to how exercise is prescribed to ensure that exercise adherence does not negatively affect RDI. Cancer site, exercise dosage, and multimodal interventions to address toxicities are key areas identified for future research.Keywords
This publication has 28 references indexed in Scilit:
- Effects of an Exercise Program in Colon Cancer Patients undergoing ChemotherapyMedicine & Science in Sports & Exercise, 2016
- Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology PracticesJournal of the National Comprehensive Cancer Network, 2015
- Cancer survivorshipCurrent Opinion in Oncology, 2015
- Effects of Exercise Dose and Type During Breast Cancer Chemotherapy: Multicenter Randomized TrialJNCI: Journal of the National Cancer Institute, 2013
- Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practiceBreast Cancer Research and Treatment, 2012
- Prevalence of Outpatient Cancer Treatment in the United States: Estimates from the Medical Panel Expenditures Survey (MEPS)Cancer Investigation, 2008
- Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled TrialJournal of Clinical Oncology, 2007
- Symptom Clusters and Physical Function for Patients Receiving ChemotherapySeminars in Oncology Nursing, 2007
- Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast CarcinomaNew England Journal of Medicine, 1994
- The calculation of actual or received dose intensity: a comparison of published methods.Journal of Clinical Oncology, 1991